In this study, we increased the sample size to 193 cases for RT-PCR, 90 cases for Western blot, and another 65 cases of glioma tissues were evaluated immunohistochemically to continually study the relationship between the overexpression of RACK1 and gliomas in depth. This evidence concerns the gene RACK1 and central nervous system cancer.